• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Environmental Monitoring - Articles and news items

Environmental Monitoring Supplement 2016

Environmental Monitoring In-Depth Focus 2016

Issue 4 2016, Supplements, Z Homepage promo / 24 August 2016 / European Pharmaceutical Review

Featuring: Bacterial endotoxin contamination and testing limits in ophthalmics; The basics of environmental monitoring in aseptic units; Environmental Monitoring Roundtable.

The challenges of riskbased environmental monitoring in sterile product filling

The challenges of riskbased environmental monitoring in sterile product filling

Issue 1 2016, Microbiology / RMMs / 29 February 2016 / James L. Drinkwater, Chairman, Pharmaceutical and Healthcare Sciences Society

Completing risk assessments is an inherent part of good manufacturing practice (GMP) and risk-based environmental control and monitoring (EM) in sterile product filling within isolators and restricted access barrier systems (RABS). This article considers the challenges the pharmaceutical industry faces in characterising conventional risk assessments like failure modes and effects analysis (FMEA) for determination of risk-based EM programs, considering aspects of the filling machine, barrier separation technology, surrounding cleanroom environment, monitoring methods/systems and process operations. The requirement for process monitoring for the manufacture of sterile medicinal products is starting to be discussed in the revision of EU GMP Annex 1, so as to bring together all EM data and hence consider the process holistically…

Whitepaper: Is it essential to sequence the entire 16S rRNA gene for bacterial identification?

Whitepaper: Is it essential to sequence the entire 16S rRNA gene for bacterial identification?

Whitepapers / 1 February 2016 / Charles River

The biopharmaceutical industry, especially manufacturing facilities, needs to implement bacterial identification to avoid the occurrence of a problematic microorganism in the final product that could be harmful for the end user and detrimental to a company’s finances and reputation…

Rainin TerraRack™ wins Green Apple Environment Award

Rainin TerraRack™ wins Green Apple Environment Award

Supplier news / 17 December 2015 / METTLER TOLEDO

METTLER TOLEDO is proud to announce that its Rainin TerraRack™ line of pipette tip racks has achieved success in this year’s Green Apple Awards…

Real-time biological particle counting in environmental monitoring

Real-time biological particle counting in environmental monitoring

Issue 2 2015, Microbiology / RMMs / 20 April 2015 / Tim Sandle, Bio Products Laboratory

The methods for monitoring air in cleanroom environments: viable counting techniques (settle plates and biological air samplers) and particle counters, are long established technologies and have been widely used in pharmaceutical manufacturing environments for decades. Although innovations have taken place with both particle counters and biological air samplers, primarily in relation to the size of the instruments and in reducing the time taken to collect a fixed volume of air, the essential technology has remained unchanged. However, recently, some new technologies for biological air sampling have been developed (bio-air systems), which will be discussed in this article…

RMMs & Environmental Monitoring: In-depth focus 2013

Issue 4 2013, Microbiology / RMMs, Supplements / 21 August 2013 / Emanuele Selvaggio (Pfizer), Chris Delaney (Noonan Services Group)

The rapid microbiological methods revolution.
Controlling contamination in the pharmaceutical industry.
Rapid Micro Methods Roundtable.

Figure 2: Showing 96 and 384 well micro-plates which have has gel based bioreactor system incorporated within the body of the plate in regions in between and surrounding the wells

A reduction to practise for siRNA screening utilising high conent analysis (HCA) technologies

Issue 3 2012, Screening / 10 July 2012 / Anthony Mitchell Davies & Anne Marie Byrne, Department of Clinical Medicine Trinity College Dublin; Holger Erfle, BIOQUANT-Zentrum Ruprecht-Karls-Universität Heidelberg; Graham Donnelly, Rita Murray & Peadar MacGabhann, Biocroi Ltd

One of the major limitations of performing large-scale High Content Analysis (HCA) screens is reagent cost, indeed this fact has been a key driver in the development of assay size reduction strategies here at The Irish National Centre for High Content Screening and Analysis at Trinity College’s Department of Medicine.

As well as the obvious financial advantages of reducing assay volumes, we have also identified other key benefits to this approach, namely: Higher throughput; Improved signal to noise; Suited for the use of valuable cells, e.g. primary cells; Reduced storage and research space; Improved mixing of reagents.

The practicalities of performing cell based assays at the nano-litre scale: Despite the clear benefits to adopting miniaturisation, there are several significant barriers that must be overcome before these methods can be utilised. These are sample delivery / handling and environmental stability.


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +